OMass Revenue and Competitors
Estimated Revenue & Valuation
- OMass's estimated annual revenue is currently $16.3M per year.
- OMass's estimated revenue per employee is $155,000
Employee Data
- OMass has 105 Employees.
- OMass grew their employee count by 5% last year.
OMass's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Office Manager and PA to the CEO | Reveal Email/Phone |
4 | SVP Finance and Operations | Reveal Email/Phone |
5 | VP Immunology | Reveal Email/Phone |
6 | VP Medicinal Chemistry | Reveal Email/Phone |
7 | VP, Pharmacology | Reveal Email/Phone |
8 | VP, Platforms and Founder | Reveal Email/Phone |
9 | Associate Director - Finance & Operations | Reveal Email/Phone |
10 | Founder & Director Technology | Reveal Email/Phone |
OMass Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is OMass?
OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona Ltd and Oxford Sciences Innovation.
keywords:N/AN/A
Total Funding
105
Number of Employees
$16.3M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
OMass News
Oxford, United Kingdom - 19 April 2022 - OMass Therapeutics ('OMass' or 'the Company'), a biotechnology company identifying medicines...
Publication in Nature by OMass Founder, Professor Dame Carol Robinson, Shows Power of Native Mass Spectrometry in Drug Discovery by...
Oxford, United Kingdom 7 March 2022 OMass Therapeutics ('OMass' or 'the Company'), a biotechnology company identifying medicines against...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $25.8M | 105 | 14% | N/A |
#2 | $7.5M | 105 | 9% | N/A |
#3 | $10.8M | 106 | 7% | N/A |
#4 | $18.2M | 107 | 35% | N/A |
#5 | $22.5M | 107 | 5% | N/A |